Real-time 3-dimensional echocardiographic evaluation of left ventricular volume: Correlation with magnetic resonance imaging—A validation study

doi:10.1067/mje.2001.113647

Journal of the American Society of Echocardiography

Volume 14, Issue 10, October 2001, Pages 1001-1009

https://doi.org/10.1067/mje.2001.113647 Get rights and content

Background:

The purpose of our study was to validate the ability of real-time 3-dimensional echocardiography (RT3D) to measure cardiac volume. Methods: We studied 25 patients with various cardiac disorders who had a regular heart rhythm and a good precordial echocardiographic window. Each patient underwent complete transthoracic echocardiography (TTE), RT3D, and magnetic resonance imaging (MRI) studies. Left ventricular dimension was calculated from slices of the whole left ventricle obtained by 7 different equidistant azimuth tilts. Planimetry of the endocardial (for volume data) and epicardium (for mass data) surface was performed for each azimuth tilt. The left ventricular end-diastolic volume (LVEDV) and the left ventricular end-systolic volume (LVESV) were calculated. The cardiac mass data were derived with the formula (Epicardial volume - LVEDV) x 1.055. The parameters of LVEDV, LVESV, stroke volume, ejection fraction, and cardiac mass were compared with those derived from MRI.

Results:

No statistically significant differences were found between the data from RT3D and MRI (P ≥ .05). Good correlations were found between these two methods for left ventricle volume and mass measurements (r from 0.92 to 0.99). However, a weaker correlation was found with larger chamber sizes because extrapolation was necessary for the volume of myocardial segments that were not covered by the small sector angle .

Conclusions:

For data acquisition, RT3D is faster than either TTE or MRI. It is also better than MRI for measuring cardiac volume and mass. To improve results with larger cardiac chamber sizes, enlargement of the sector angle will be necessary.

References (35)

DevereuxR.B. et al.
Echocardiographic determination of left ventricular hypertrophy: comparison to necropsy findings
Am J Cardiol
(1986)
PattynamaP.M.T. et al.
Evaluation of cardiac function with magnetic resonance imaging
Am Heart J
(1994)
JiangL. et al.
Three-dimensional echocardiographic reconstruction of right ventricular volume: in vitro comparison with two-dimensional methods
J Am Soc Echocardiogr
(1994)
PiniR. et al.
Transthoracic three-dimensional echocardiographic reconstruction of left and right ventricles: in vitro validation and comparison with magnetic resonance imaging
Am Heart J
(1997)
MasonS.J. et al.
The use of echocardiography for quantitative evaluation of left ventricular function
Prog Cardiovasc Dis
(1978)
MartinE.T. et al.
Imaging cardiac structure and pump function
Cardiol Clin
(1998)
DevereuxR.B. et al.
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings
Am J Cardiol
(1986)
LevyD. et al.
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
N Engl J Med
(1990)
LevyD. et al.
Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study
Ann Intern Med
(1989)
CasaleP.N. et al.
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
Ann Intern Med
(1986)

DevereuxR.B. et al.

Echocardiographic determination of left ventricular mass in man: anatomic validation of the method

Circulation

(1977)

TroyB.L. et al.

Measurements of left ventricular wall thickness and mass by echocardiography

Circulation

(1972)

HelakJ.W. et al.

Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomic validation

Circulation

(1981)

ReichekN. et al.

Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results

Circulation

(1983)

SchillerN.B. et al.

Canine left ventricular mass estimation by two-dimensional echocardiology

Circulation

(1983)

SechtemU. et al.

Measurement of right and left ventricular volume in healthy individuals with tine MR imaging

Radiology

(1987)

VogelM. et al.

In vitro validation of right ventricular volume measurement by three-dimensional echocardiography

Br Heart J

(1995)

Cited by (50)

Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete?
2017, JACC: Heart Failure
Diagnosis, prognosis, treatment, and development of new therapies for diseases or syndromes depend on a reliable means of identifying phenotypes associated with distinct predictive probabilities for these various objectives. Left ventricular ejection fraction (LVEF) provides the current basis for combined functional and structural phenotyping in heart failure by classifying patients as those with heart failure with reduced ejection fraction (HFrEF) and those with heart failure with preserved ejection fraction (HFpEF). Recently the utility of LVEF as the major phenotypic determinant of heart failure has been challenged based on its load dependency and measurement variability. We review the history of the development and adoption of LVEF as a critical measurement of LV function and structure and demonstrate that, in chronic heart failure, load dependency is not an important practical issue, and we provide hemodynamic and molecular biomarker evidence that LVEF is superior or equal to more unwieldy methods of identifying phenotypes of ventricular remodeling. We conclude that, because it reliably measures both left ventricular function and structure, LVEF remains the best current method of assessing pathologic remodeling in heart failure in both individual clinical and multicenter group settings. Because of the present and future importance of left ventricular phenotyping in heart failure, LVEF should be measured by using the most accurate technology and methodologic refinements available, and improved characterization methods should continue to be sought.
Inaccuracy of the FloTrac/vigileo<sup>TM</sup> system in patients with low cardiac index
2014, Journal of Cardiothoracic and Vascular Anesthesia
The goal of this study was to compare cardiac output derived from the FloTrac/Vigileo™ system (CO_FT) with cardiac output measured by 3-dimensional transesophageal echocardiography (CO_3D) in patients with severe heart failure undergoing cardiac resynchronization therapy. The impact of preoperative systemic vascular resistance index on the accuracy of the FloTrac/Vigileo™ system also was investigated.
Prospective clinical study.
Cardiac surgery operating room of a single cardiovascular center.
Forty-one patients undergoing elective cardiac resynchronization therapy lead implantation.
CO_3D as the reference method and CO_FT were determined simultaneously after induction of anesthesia.
Linear regression analysis showed a poor correlation between CO_3D and CO_FT (R² = 0.16). Bland–Altman plots showed wide limits of agreement between CO_3D and CO_FT.. Bias was 0.60±0.63 L/min with a high percentage error of 58.2%. Subgroup analysis showed that the percentage error between CO_3D and CO_FT was 74.1% in patients with a cardiac index<2.2 L/min/m² and 17.2% in patients with a cardiac index≥2.2 L/min/m². Systemic vascular resistance index was significantly higher in patients with a cardiac index<2.2 L/min/m² (3,037±820 v 2,461±878; p = 0.039).
The FloTrac/Vigileo™ system is not accurate in patients with low cardiac output, especially those with a cardiac index<2.2 L/min/m². A high systemic vascular resistance index in patients with low cardiac index may contribute to this inaccuracy.
Ultrasonography for haemodynamic monitoring
2014, Best Practice and Research: Clinical Anaesthesiology
Citation Excerpt :
Smith et al. demonstrated that the 2D TOE measurements of EF correlated well with values measured by LV angiography (correlation coefficient r = 0.85 for EF) [18]. Transthoracic 3D measurements of ventricular volumes and EF show an even better correlation with reference standards (such as magnetic resonance imaging (MRI) or single-photon emission computed tomography (SPECT)), because no assumptions about ventricular geometry are necessary [19,20]. SV can also be evaluated by TOE: Utilizing Doppler, the velocity of blood flow passing a known cross-sectional area (CSA) within a period of time is measured (velocity–time integral (VTI)).
Echocardiography has become an indispensable tool in the evaluation of medical and surgical patients. As ultrasound (US) machines have become more widely available and significantly more compact, there has been an exponential growth in the use of transthoracic echocardiography (TTE), transoesophageal echocardiography (TOE) and other devices in the perioperative setting. Here, we review recent findings relevant to the use of perioperative US, with a special focus on the haemodynamic management of the surgical patient.
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography
2012, Journal of the American Society of Echocardiography
Real-Time Transthoracic Three Dimensional Echocardiography: Normal Reference Data for Left Ventricular Dyssynchrony in Adolescents
2009, Journal of the American Society of Echocardiography
Citation Excerpt :
Furthermore, no comparison was made with other techniques, such as angiocardiography or magnetic resonance imaging. Values obtained in the present study, however, were not different from values obtained in previous smaller series, and the dimensional accuracy of three-dimensional echocardiography has been demonstrated in various studies.2,24,25 Because we studied healthy adolescents who usually had good echocardiographic windows and were able to cooperate, especially considering breath holds, we cannot draw conclusions about the feasibility of our method in patients after multiple cardiac operations or with thoracic deformities.
Since the introduction of cardiac resynchronization therapy, the assessment of left ventricular (LV) dyssynchrony has become increasingly important. Real-time three-dimensional echocardiography (RT-3DE) is one of the methods that is increasingly used. However, normal reference data in a young population are scarce.
RT-3DE was performed in 73 healthy adolescents aged 12 to 18 years. A systolic dyssynchrony index was derived from the dispersion of time to minimum regional volume for all 16 LV segments.
Acquisition of RT-3DE data sets was feasible in 67 of 73 subjects (92%). LV end-diastolic volume and LV end-systolic volume were 99 ± 25 and 41 ± 15 mL, respectively. All controls had highly synchronized segmental function (systolic dyssynchrony index, 1.26 ± 0.53%). Dyssynchrony was independent of age, weight, or length. Interobserver variability for the dyssynchrony index was 2 ± 2 ms and 0.3 ± 0.2% for the absolute and heart rate–corrected values, respectively. Intraobserver variability was 2.0 ± 0.07 ms and 0.0 ± 0.27%, respectively.
RT-3DE could be performed in most healthy adolescents with good interobserver and intraobserver variability. Highly synchronized segmental function was present and was independent of age, weight, or length.
Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging Measurements of Functional Single Ventricular Volumes, Mass, and Ejection Fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)
2009, American Journal of Cardiology
Citation Excerpt :
Extrapolation from these studies to FSVs should yield similar results, because chamber geometry and orientation within the thorax are often unpredictable, and imaging of the anterior, retrosternal free wall is often challenging. Although 3-dimensional echocardiography holds promise for the more accurate assessment of ventricular volume in biventricular circulation,11–15 its accuracy and reproducibility in patients with FSVs await confirmation. Soriano et al16 recently demonstrated that measurements of FSV volumes, EF, and mass by 3-dimensional echocardiography correlate well with CMR measurements.
Assessment of the size and function of a functional single ventricle (FSV) is a key element in the management of patients after the Fontan procedure. Measurement variability of ventricular mass, volume, and ejection fraction (EF) among observers by echocardiography and cardiac magnetic resonance imaging (CMR) and their reproducibility among readers in these patients have not been described. From the 546 patients enrolled in the Pediatric Heart Network Fontan Cross-Sectional Study (mean age 11.9 ± 3.4 years), 100 echocardiograms and 50 CMR studies were assessed for measurement reproducibility; 124 subjects with paired studies were selected for comparison between modalities. Interobserver agreement for qualitative grading of ventricular function by echocardiography was modest for left ventricular (LV) morphology (κ = 0.42) and weak for right ventricular (RV) morphology (κ = 0.12). For quantitative assessment, high intraclass correlation coefficients were found for echocardiographic interobserver agreement (LV 0.87 to 0.92, RV 0.82 to 0.85) of systolic and diastolic volumes, respectively. In contrast, intraclass correlation coefficients for LV and RV mass were moderate (LV 0.78, RV 0.72). The corresponding intraclass correlation coefficients by CMR were high (LV 0.96, RV 0.85). Volumes by echocardiography averaged 70% of CMR values. Interobserver reproducibility for the EF was similar for the 2 modalities. Although the absolute mean difference between modalities for the EF was small (<2%), 95% limits of agreement were wide. In conclusion, agreement between observers of qualitative FSV function by echocardiography is modest. Measurements of FSV volume by 2-dimensional echocardiography underestimate CMR measurements, but their reproducibility is high. Echocardiographic and CMR measurements of FSV EF demonstrate similar interobserver reproducibility, whereas measurements of FSV mass and LV diastolic volume are more reproducible by CMR.

View all citing articles on Scopus

¹: From the Division of Cardiology, Veteran General Hospital-Kaohsiung, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC

²: Echocardiographic Laboratory, Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham (A.R.F., P.-H.F.).

³: the Division of Cardiology, Veteran General Hospital-Taipei, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC (T.-L.H.)

View full text

Real-time 3-dimensional echocardiographic evaluation of left ventricular volume: Correlation with magnetic resonance imaging—A validation study

Background:

Results:

Conclusions:

Am J Cardiol

Am Heart J

J Am Soc Echocardiogr

Am Heart J

Prog Cardiovasc Dis

Cardiol Clin

Am J Cardiol

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

N Engl J Med

Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study

Ann Intern Med

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

Ann Intern Med

Echocardiographic determination of left ventricular mass in man: anatomic validation of the method

Circulation

Measurements of left ventricular wall thickness and mass by echocardiography

Circulation

Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomic validation

Circulation

Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results

Circulation

Canine left ventricular mass estimation by two-dimensional echocardiology

Circulation

Measurement of right and left ventricular volume in healthy individuals with tine MR imaging

Radiology

In vitro validation of right ventricular volume measurement by three-dimensional echocardiography

Br Heart J